Skip to contentGREER R SCOTT — NEKTAR THERAPEUTICS insider: 150 transactions · InsiderLensGREER R SCOTT
- Director at SIRNA THERAPEUTICS INC · on record since Jun 16, 2006
- Director at ABGENIX INC · on record since Apr 4, 2006
- Director at ILLUMINA INC · on record since May 21, 2004
- Director at NEKTAR THERAPEUTICS · on record since Feb 3, 2010
- Director at STEMCELLS INC · on record since Jun 10, 2010
- Director at CV THERAPEUTICS INC · on record since Dec 15, 2003
- Director at Auspex Pharmaceuticals, Inc. · on record since May 7, 2014
- Director at NETWORK INSTALLATION CORP · on record since Oct 28, 2014
- Director at Versartis, Inc. · on record since Dec 11, 2014
- Director at INTROGEN THERAPEUTICS INC · on record since Aug 26, 2015
Insider trading activity of GREER R SCOTT
- Transactions on record
- 150
- since Aug 14, 2003
- Open-market buys
- 9
- $649K
- Open-market sells
- 5
- $4.4M
- Companies traded
- 10
- last filing Oct 1, 2025
Figures computed from official regulatory filings — methodology.
Companies where GREER R SCOTT has traded
- NEKTAR THERAPEUTICS66 tx · $9M · Oct 1, 2025
- INTROGEN THERAPEUTICS INC23 tx · $901.6K · May 12, 2021
- NETWORK INSTALLATION CORP5 tx · $525K · Jun 7, 2018
- Versartis, Inc.12 tx · $196.6K · Dec 22, 2017
- STEMCELLS INC6 tx · Jan 5, 2016
- Auspex Pharmaceuticals, Inc.4 tx · $99.9K · May 6, 2015
- SIRNA THERAPEUTICS INC18 tx · Jan 4, 2007
- ABGENIX INC14 tx · $6.9M · Apr 4, 2006
- ILLUMINA INC1 tx · May 21, 2004
- CV THERAPEUTICS INC
Track record of GREER R SCOTT
Statistical track record
Free- Open-market buys
- 10
- Last buy
- May 7, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of GREER R SCOTT
Co-insiders of GREER R SCOTT
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
1 tx · Dec 15, 2003
WHITFIELD ROY AILLUMINA INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Oct 1, 2025 | AwardD | 8,000 | 0.00 USD | $0 | SEC |
| Jan 17, 2025 | AwardD | 120,000 | 0.00 USD | $0 | SEC |
| Sep 21, 2023 | AwardD | 85,000 | 0.00 USD | $0 | SEC |
| Sep 20, 2022 | AwardD | 20,400 | 0.00 USD | $0 | SEC |
| Sep 20, 2022 | Award | 10,200 | 0.00 USD | $0 | SEC |
| Nov 9, 2021 | ExerciseD | -12,500 | 0.00 USD | $0 | SEC |
| Nov 9, 2021 | Exercise | 12,500 | 12.80 USD | $160K | SEC |
| Sep 24, 2021 | AwardD | 20,400 | 0.00 USD | $0 | SEC |
| Sep 24, 2021 | Award | 10,200 | 0.00 USD | $0 | SEC |
| Aug 31, 2021 | Exercise | 45,000 | 12.70 USD | $571.5K | SEC |
| Aug 31, 2021 | ExerciseD | -45,000 | 0.00 USD | $0 | SEC |
| May 12, 2021 | Award | 2,754 | 0.00 USD | $0 | SEC |
| Feb 4, 2021 | ExerciseD | -6,666 | 0.00 USD | $0 | SEC |
| Feb 4, 2021 | Exercise | 6,666 | 46.66 USD | $311K | SEC |
| Feb 4, 2021 | Exercise | 10,000 | 44.19 USD | $441.9K | SEC |
| Feb 4, 2021 | ExerciseD | -10,000 | 0.00 USD | $0 | SEC |
| Feb 4, 2021 | Exercise | 3,334 | 43.21 USD | $144.1K | SEC |
| Feb 4, 2021 | ExerciseD | -3,334 | 0.00 USD | $0 | SEC |
| Jan 5, 2021 | ExerciseD | -40,000 | 0.00 USD | $0 | SEC |
| Jan 5, 2021 | Exercise | 40,000 | 13.80 USD | $552K | SEC |
| Sep 25, 2020 | Award | 9,100 | 0.00 USD | $0 | SEC |
| Sep 25, 2020 | AwardD | 18,200 | 0.00 USD | $0 | SEC |
| Sep 24, 2020 | AwardD | 18,200 | 0.00 USD | $0 | SEC |
| Sep 24, 2020 | Award | 9,100 | 0.00 USD | $0 | SEC |
| Jul 10, 2020 | Sell | -15,009 | 25.00 USD | $375.2K | SEC |